nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.0231	0.0364	CcSEcCtD
Maprotiline—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.0203	0.0321	CcSEcCtD
Maprotiline—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0158	0.0249	CcSEcCtD
Maprotiline—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.0146	0.0231	CcSEcCtD
Maprotiline—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0132	0.0209	CcSEcCtD
Maprotiline—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.0132	0.0209	CcSEcCtD
Maprotiline—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0128	0.0202	CcSEcCtD
Maprotiline—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.02	CcSEcCtD
Maprotiline—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0126	0.0199	CcSEcCtD
Maprotiline—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0126	0.0198	CcSEcCtD
Maprotiline—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0194	CcSEcCtD
Maprotiline—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0187	CcSEcCtD
Maprotiline—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0186	CcSEcCtD
Maprotiline—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0169	CcSEcCtD
Maprotiline—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0165	CcSEcCtD
Maprotiline—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0162	CcSEcCtD
Maprotiline—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0159	CcSEcCtD
Maprotiline—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00998	0.0157	CcSEcCtD
Maprotiline—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00946	0.0149	CcSEcCtD
Maprotiline—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00932	0.0147	CcSEcCtD
Maprotiline—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00927	0.0146	CcSEcCtD
Maprotiline—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00913	0.0144	CcSEcCtD
Maprotiline—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00913	0.0144	CcSEcCtD
Maprotiline—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.009	0.0142	CcSEcCtD
Maprotiline—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00895	0.0141	CcSEcCtD
Maprotiline—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00895	0.0141	CcSEcCtD
Maprotiline—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0089	0.0141	CcSEcCtD
Maprotiline—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.0089	0.0141	CcSEcCtD
Maprotiline—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00864	0.0136	CcSEcCtD
Maprotiline—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0082	0.0129	CcSEcCtD
Maprotiline—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00816	0.0129	CcSEcCtD
Maprotiline—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0081	0.0128	CcSEcCtD
Maprotiline—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00804	0.0127	CcSEcCtD
Maprotiline—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00764	0.0121	CcSEcCtD
Maprotiline—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00761	0.012	CcSEcCtD
Maprotiline—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00744	0.0117	CcSEcCtD
Maprotiline—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00739	0.0117	CcSEcCtD
Maprotiline—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00732	0.0116	CcSEcCtD
Maprotiline—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00724	0.0114	CcSEcCtD
Maprotiline—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00714	0.0113	CcSEcCtD
Maprotiline—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.007	0.0111	CcSEcCtD
Maprotiline—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00699	0.011	CcSEcCtD
Maprotiline—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00693	0.0109	CcSEcCtD
Maprotiline—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00673	0.0106	CcSEcCtD
Maprotiline—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00669	0.0106	CcSEcCtD
Maprotiline—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00656	0.0104	CcSEcCtD
Maprotiline—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00639	0.0101	CcSEcCtD
Maprotiline—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00618	0.00976	CcSEcCtD
Maprotiline—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00616	0.00973	CcSEcCtD
Maprotiline—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00605	0.00956	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00603	0.00952	CcSEcCtD
Maprotiline—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00594	0.00938	CcSEcCtD
Maprotiline—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00587	0.00927	CcSEcCtD
Maprotiline—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00582	0.00919	CcSEcCtD
Maprotiline—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00579	0.00913	CcSEcCtD
Maprotiline—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00571	0.00902	CcSEcCtD
Maprotiline—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.0057	0.009	CcSEcCtD
Maprotiline—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00566	0.00893	CcSEcCtD
Maprotiline—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00563	0.00889	CcSEcCtD
Maprotiline—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00527	0.00832	CcSEcCtD
Maprotiline—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.00826	CcSEcCtD
Maprotiline—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00518	0.00817	CcSEcCtD
Maprotiline—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00513	0.00809	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00503	0.00794	CcSEcCtD
Maprotiline—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00502	0.00793	CcSEcCtD
Maprotiline—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00498	0.00786	CcSEcCtD
Maprotiline—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0048	0.00758	CcSEcCtD
Maprotiline—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00476	0.00752	CcSEcCtD
Maprotiline—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.0073	CcSEcCtD
Maprotiline—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.00727	CcSEcCtD
Maprotiline—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.00727	CcSEcCtD
Maprotiline—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00418	0.0066	CcSEcCtD
Maprotiline—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00412	0.0065	CcSEcCtD
Maprotiline—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00398	0.00629	CcSEcCtD
Maprotiline—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00385	0.00608	CcSEcCtD
Maprotiline—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.0037	0.00585	CcSEcCtD
Maprotiline—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00367	0.0058	CcSEcCtD
Maprotiline—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00367	0.00579	CcSEcCtD
Maprotiline—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00365	0.00576	CcSEcCtD
Maprotiline—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00346	0.00546	CcSEcCtD
Maprotiline—HTR2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000383	0.00105	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000382	0.00104	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000381	0.00104	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000381	0.00104	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00038	0.00104	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000377	0.00103	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000376	0.00103	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000375	0.00102	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000374	0.00102	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000374	0.00102	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00037	0.00101	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00037	0.00101	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000368	0.00101	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000368	0.001	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000368	0.001	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000367	0.001	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000366	0.001	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000365	0.000996	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000364	0.000992	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000362	0.000987	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000359	0.00098	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000358	0.000977	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000357	0.000973	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000354	0.000966	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000352	0.000961	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000352	0.000959	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000351	0.000959	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00035	0.000956	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000349	0.000953	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000347	0.000946	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000346	0.000943	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000343	0.000935	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000343	0.000935	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000342	0.000933	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000341	0.00093	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00034	0.000928	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00034	0.000927	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000339	0.000925	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000339	0.000925	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000338	0.000922	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000335	0.000914	CbGpPWpGaD
Maprotiline—SLC6A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.00033	0.000899	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000326	0.00089	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000324	0.000883	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000323	0.000881	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000321	0.000876	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000317	0.000865	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000315	0.000859	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000312	0.000851	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000311	0.000849	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000311	0.000849	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00031	0.000846	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00031	0.000846	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00031	0.000845	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000309	0.000844	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000309	0.000843	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000309	0.000843	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000308	0.00084	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000307	0.000839	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000307	0.000838	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000306	0.000836	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000305	0.000831	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000304	0.00083	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000304	0.00083	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000302	0.000825	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000298	0.000812	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000297	0.00081	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000296	0.000808	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000295	0.000805	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000294	0.000802	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000292	0.000797	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000292	0.000797	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000288	0.000785	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000286	0.00078	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000283	0.000773	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000283	0.000771	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000282	0.000769	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000282	0.000768	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000281	0.000766	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000278	0.000759	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000277	0.000754	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00027	0.000736	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000269	0.000733	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000268	0.000731	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000267	0.00073	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000264	0.000721	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000264	0.00072	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000263	0.000718	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000262	0.000715	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000261	0.000713	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00026	0.000708	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000258	0.000705	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000253	0.00069	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000252	0.000688	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000251	0.000684	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000247	0.000673	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000244	0.000666	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00024	0.000655	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00024	0.000654	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000239	0.000652	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000238	0.00065	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000236	0.000645	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000236	0.000643	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000235	0.000642	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000231	0.000631	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00023	0.000626	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000223	0.000609	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000222	0.000607	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000222	0.000605	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000221	0.000603	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000219	0.000599	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000219	0.000598	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000219	0.000597	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000218	0.000596	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000218	0.000596	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000218	0.000594	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000218	0.000594	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000218	0.000594	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000217	0.000592	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000217	0.000592	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000217	0.000592	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000216	0.00059	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000216	0.000589	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000216	0.000588	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000215	0.000587	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000215	0.000586	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000214	0.000583	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000211	0.000575	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000209	0.000571	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000204	0.000556	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000203	0.000554	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000203	0.000553	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.0002	0.000547	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000199	0.000544	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000199	0.000543	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000198	0.000541	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000198	0.000539	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000196	0.000534	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000194	0.00053	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000193	0.000526	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000192	0.000525	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000186	0.000507	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000186	0.000506	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000184	0.000502	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000184	0.000502	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000183	0.000499	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000183	0.000498	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000182	0.000496	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000181	0.000495	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00018	0.00049	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000174	0.000474	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00017	0.000464	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00017	0.000464	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00017	0.000463	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000167	0.000456	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000167	0.000456	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000166	0.000454	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000166	0.000454	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000166	0.000453	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000164	0.000448	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000163	0.000446	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—LPL—focal segmental glomerulosclerosis	0.000163	0.000445	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00016	0.000438	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00016	0.000436	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000159	0.000433	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000158	0.000432	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000154	0.000419	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00015	0.00041	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000149	0.000408	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000145	0.000396	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000144	0.000393	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000142	0.000387	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000142	0.000386	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000141	0.000386	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000141	0.000385	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000141	0.000384	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000141	0.000384	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00014	0.000382	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AGT—focal segmental glomerulosclerosis	0.00014	0.000381	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000139	0.00038	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000138	0.000376	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000138	0.000375	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000137	0.000375	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000137	0.000373	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000136	0.000372	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000136	0.00037	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000135	0.00037	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000135	0.000369	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000134	0.000364	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000132	0.000361	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00013	0.000356	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00013	0.000355	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00013	0.000354	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00013	0.000354	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000129	0.000353	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000128	0.000349	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000128	0.000349	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000125	0.000342	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000122	0.000332	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00012	0.000326	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000119	0.000325	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000118	0.000321	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000117	0.000321	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000117	0.00032	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000117	0.000318	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000116	0.000315	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000111	0.000302	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00011	0.0003	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000109	0.000297	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000109	0.000296	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000108	0.000296	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000108	0.000295	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000108	0.000294	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ALB—focal segmental glomerulosclerosis	0.000107	0.000292	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000107	0.000291	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000104	0.000284	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	0.000104	0.000283	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000102	0.000279	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.8e-05	0.000267	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	9.76e-05	0.000266	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.2e-05	0.000251	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.05e-05	0.000247	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.03e-05	0.000246	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9e-05	0.000246	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.98e-05	0.000245	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.93e-05	0.000244	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.89e-05	0.000243	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	8.86e-05	0.000242	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.43e-05	0.00023	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	8.35e-05	0.000228	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	8.27e-05	0.000226	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.07e-05	0.00022	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.99e-05	0.000218	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	7.07e-05	0.000193	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.05e-05	0.000192	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.93e-05	0.000189	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.92e-05	0.000189	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.9e-05	0.000188	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.88e-05	0.000188	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.81e-05	0.000186	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	6.8e-05	0.000185	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.58e-05	0.00018	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	6.41e-05	0.000175	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.81e-05	0.000158	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.72e-05	0.000156	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.7e-05	0.000156	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.68e-05	0.000155	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.67e-05	0.000155	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.61e-05	0.000153	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	5.43e-05	0.000148	CbGpPWpGaD
